Kardigan Files for Nasdaq Listing, Proposes 'KARD' Ticker
(Updated - May 26, 2026 4:26 PM EDT) Kardigan, Inc filed paperwork on Tuesday seeking a Nasdaq initial public offering under the symbol KARD. The clinical-stage firm says it focuses on precision therapeutics for cardiovascular diseases with no approved treatments and listed four firms as underwriters.